SelectQuote (SLQT) just reported a busy Q2 2026, with total revenue of US$537.1 million and net income of US$51.2 million, which translated to basic EPS of US$0.27. The company’s quarterly revenue had previously stood at US$481.1 million with EPS of US$0.31 in Q2 2025, followed by a mix of losses and profits in subsequent periods, before arriving at the current quarter’s figures. For you as an investor, this latest report highlights a balance between improving profitability on one hand and the pressure that margins and interest costs can place on how sustainable those earnings appear on the other.

See our full analysis for SelectQuote.

With the headline numbers established, the next step is to see how they compare with the current narratives around SelectQuote’s growth prospects, profitability quality, and risk profile.

TTM profit of US$19.6 million sits on uneven quarterly path

• On a trailing 12 month basis, SelectQuote earned US$19.6 million of net income on US$1.6b of revenue, compared with a mix of quarterly profits and losses that ranged from a loss of US$47.9 million in Q1 2026 to a profit of US$53.2 million in Q2 2025.
• What stands out against the bullish view that margin expansion could meaningfully accelerate profitability is that quarterly EPS has swung from a loss of US$0.26 in Q1 2026 to a profit of US$0.27 in Q2 2026. This suggests the current TTM profit is built on results that have not yet settled into a consistent pattern.
  • Bulls highlight the potential for higher EBITDA margins over time from technology and automation, yet the last six quarters include three loss making periods, showing that any margin story still runs through periods of earnings pressure.
  • The optimistic narrative points to recurring, higher margin healthcare revenue streams, while the actual results across 2025 and early 2026 show profitability moving between US$51.2 million profit and US$47.9 million loss, which may make it harder to treat the latest quarter as a clean read on that thesis.

On these figures, bulls are essentially asking you to look past the bumpy earnings path to a smoother margin story over time. This is where the detailed bullish narrative comes in if you want to see how that case is built out 🐂 SelectQuote Bull Case.

Forecast EPS decline against a lower 11.2x P/E

• SelectQuote trades on a trailing P/E of 11.2x against a US$1.24 share price, while analysts are forecasting earnings to decline by about 5.4% per year over the next three years and expecting revenue growth of roughly 5.3% per year.
• Bears focus on this combination of a shrinking earnings outlook and weaker interest coverage to argue that even a below market P/E can be questioned when earnings are not expected to build from the current TTM base of US$19.6 million.
  • Critics point out that earnings are not covering interest payments, so any decline from the current profit level could make it harder for the company to improve its balance sheet, which is a key part of the cautious narrative.
  • The bearish view also highlights that projected revenue growth of 5.3% a year sits below the 11.2% market forecast, so the 11.2x P/E multiple is being placed on a business profile that is expected to see slower growth and weaker earnings rather than on a higher growth, strengthening earnings story.

Taken together, these points line up closely with the concerns skeptics raise about how much support a discounted multiple really provides when earnings are forecast to trend lower 🐻 SelectQuote Bear Case.

P/E discount and US$3.06 target sit beside volatile share price

• The trailing P/E of 11.2x sits below the US market at 19.1x, below the US insurance industry at 11.3x, and well below a peer average of 35.6x, while the current US$1.24 share price is also below the US$3.06 analyst consensus target.
• Consensus narrative calls out that revenue growth expectations and balance sheet work are positives, yet the same data set flags high share price volatility over the last three months and weak interest coverage. This means the apparent valuation discount and the gap to the US$3.06 target are being weighed against more fragile earnings and capital structure metrics.
  • Supporters of the consensus view point to SelectQuote having turned profitable on a TTM basis, but the combination of forecast earnings decline and recent price swings means that the lower P/E and target upside are not being read as a simple signal of strength.
  • The fact that the P/E is below both market and industry while interest payments are not covered by earnings underlines why some investors may see the discount as compensation for leverage and earnings risk, not just an unrecognised opportunity.

Next Steps

To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for SelectQuote on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.

With sentiment in this article pulling in both cautious and optimistic directions, it makes sense to review the numbers yourself and decide where you stand. If you want a clear summary of what could go right and what could go wrong next, start with these 3 key rewards and 3 important warning signs.

See What Else Is Out There

SelectQuote is wrestling with uneven profitability, weak interest coverage, and an earnings outlook that analysts expect to decline despite the current P/E discount.

If that mix of bumpy profits and balance sheet pressure feels uncomfortable, you can immediately narrow your focus to companies screened for stronger financial footing with the solid balance sheet and fundamentals stocks screener (46 results).

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.